Your browser doesn't support javascript.
loading
Sonodynamic therapy: A potential treatment for atherosclerosis.
Geng, Chi; Zhang, Yunlong; Hidru, Tesfaldet Habtemariam; Zhi, Lianyun; Tao, Mengxing; Zou, Leixin; Chen, Chen; Li, Huihua; Liu, Ying.
Afiliação
  • Geng C; Department of Cardiology, Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Zhang Y; School of Public Health, Dalian Medical University, Dalian, China.
  • Hidru TH; School of Public Health, Dalian Medical University, Dalian, China.
  • Zhi L; Department of Cardiology, Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Tao M; Department of Neurology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Zou L; School of Public Health, Dalian Medical University, Dalian, China.
  • Chen C; School of Public Health, Dalian Medical University, Dalian, China.
  • Li H; Department of Cardiology, Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China. Electronic address: hhli1935@aliyun.com.
  • Liu Y; Department of Cardiology, Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China. Electronic address: 18098875801@163.com.
Life Sci ; 207: 304-313, 2018 Aug 15.
Article em En | MEDLINE | ID: mdl-29940244
ABSTRACT
Atherosclerosis (AS), a chronic arterial disease, is one of the major causes of morbidity and mortality worldwide. Several treatment modalities have been demonstrated to be effective in treating AS; however, the mortality rate due to AS remains high. Sonodynamic therapy (SDT) is a promising new treatment using low-intensity ultrasound in combination with sonosensitizers. Although SDT was developed from photodynamic therapy (PDT), it has a stronger tissue-penetrating capability and exhibits a more focused effect on the target lesional site requiring treatment. Furthermore, SDT has been demonstrated to suppress the formation of atheromatous plaques, and it can increase plaque stability both in vitro and in vivo. In this article, we critically summarize the recent literature on SDT, focusing on its possible mechanism of action as well as the existing and newly discovered sonosensitizers and chemotherapeutic agents for the treatment of AS.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia por Ultrassom / Aterosclerose Limite: Animals / Humans Idioma: En Revista: Life Sci Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia por Ultrassom / Aterosclerose Limite: Animals / Humans Idioma: En Revista: Life Sci Ano de publicação: 2018 Tipo de documento: Article